The Trump administration on Tuesday moved to add 7-OH, a psychoactive compound derived from the kratom plant, to the schedule ...

Last year in March, Drap directed a pharmaceutical company to recall a syrup, which is given to children to treat fever, from ...

On July 22, 2025, the US Food and Drug Administration (FDA) started accepting applications to participate in the Commissioner’s National ...

CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and ...

Federal officials said a psychoactive ingredient in kratom had been refined and added to supplements that could quickly ...

The Drug Regulatory Authority of Pakistan (Drap) on Tuesday directed three pharmaceutical companies to recall “substandard” ...

ClariMed, Inc., a global leader in human-centered medical device development and regulatory services, today announced it has ...

Turkish, Kazakh officials sign deals on various areas of cooperation during official visit by Kazakh president to Ankara - ...

Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging technology company developing healthcare solutions, and its Joint Venture partner, Ainnova Tech, Inc. (Ainnova), a leading ...

According to DRAP, the syringes in question failed crucial quality control tests. The Zindagi Auto Disable Syringe was ...